PRPrivia PRVA · NASDAQ
$24.42 +2.01% (+$0.48)
- Market cap
- $3.06B
- Enterprise value
- -$400.4B
- P/E
- 108.7x
- Forward P/E
- 93.9x
- PEG
- 2.2x
- P/S
- 1.3x
- P/FCF
- -
- EV/EBITDA
- -
- ROIC
- 0.0%
- Gross margin
- 7.6%
- Net margin
- 1.2%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -5,918.9x
- Beta
- 0.80
- Free float
- 85.3%
About the company
Privia Health Group, Inc. is an American healthcare company that focuses on providing comprehensive healthcare through its care management and coordination platform. Founded in 2007, the company's main activity is supporting healthcare providers, such as doctors and clinics, in improving care quality and treatment efficiency. Privia Health leverages advanced technologies and analytics to optimize healthcare data management processes, enabling physicians to offer personalized care and improve patient outcomes. The company operates primarily in the U.S., collaborating with thousands of physicians across various specialties.
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Parth Mehrotra
Employees
1,226
Headquarters
Arlington
Valuation
Is today's price reasonable?
- What speaks for it: The share price is below the Bulios Fair Price.
Growth and estimates
Is it growing, and what comes next?
- What speaks for it: Revenue grew by 16% a year over the last 3 years.
- What speaks for it: Analysts expect revenue to grow by 16% this fiscal year.
- What to watch: It missed profit estimates 5 times in the last 8 quarters.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What to watch: Out of every 100 USD of revenue, only 1.2 USD is left as net profit.
- What to watch: It earns only 0.0 USD a year on every 100 USD of invested capital.
Financial health
Can it carry its debt?
- What speaks for it: It holds more cash than debt: $446.3M against $8.26M.
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number